Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Biopharm Stat. 2015 Jun 22;26(3):475–498. doi: 10.1080/10543406.2015.1052492

Table 4.

Probability of toxicity estimates based on 500 simulated datasets containing N = 10 and N = 30 patients receiving one of five dose groups d1 . . . d5 over six cycles comparing estimates based on Model 3 to estimates based on Models 6 and 7. Results presented for α = 1, β = 0.5 and ρ = 0.8 and with patients distributed equally on the five dose levels.

N = 10 N = 30
Estimate(Bias) ESD1 Estimate(Bias) ESD1
First cycle
Markov Model 3
        d 1 0.019 (−0.001) 0.011 0.020 (< 0.001) 0.008
        d 2 0.047 (−0.003) 0.028 0.049 (−0.001) 0.020
        d 3 0.093 (−0.007) 0.053 0.098 (−0.002) 0.038
        d 4 0.148 (−0.012) 0.081 0.156 (−0.004) 0.059
        d 5 0.21 (−0.02) 0.109 0.223 (−0.007) 0.081
Binary Model 6
        d 1 0.018 (−0.002) 0.012 0.019 (−0.001) 0.008
        d 2 0.045 (−0.005) 0.030 0.047 (−0.003) 0.021
        d 3 0.090 (−0.010) 0.057 0.093 (−0.007) 0.040
        d 4 0.143 (−0.017) 0.086 0.149 (−0.011) 0.062
        d 5 0.203 (−0.027) 0.114 0.213 (−0.017) 0.085
Any cycle
Markov Model 3
        d 1 0.038 (−0.004) 0.021 0.042 (−0.001) 0.016
        d 2 0.105 (−0.011) 0.050 0.113 (−0.002) 0.038
        d 3 0.234 (−0.021) 0.092 0.250 (−0.005) 0.068
        d 4 0.405 (−0.033) 0.132 0.428 (−0.010) 0.095
        d 5 0.598 (−0.046) 0.152 0.626 (−0.019) 0.109
Binary Model 7
        d 1 0.041 (−0.001) 0.022 0.042 (< 0.001) 0.014
        d 2 0.111 (−0.004) 0.055 0.114 (−0.001) 0.035
        d 3 0.241 (−0.014) 0.107 0.251 (−0.004) 0.070
        d 4 0.407 (−0.032) 0.153 0.428 (−0.011) 0.102
        d 5 0.590 (−0.055) 0.176 0.624 (−0.02) 0.115
1

ESD is empirical SD of the 500 estimates